Intelligent Automation Services for Life Sciences

Intelligent automation combines Robotic Process Automation (RPA), Intelligent Document Processing (IDP), AI-powered workflow orchestration, and machine learning models. In life sciences, this spans clinical data entry automation, regulatory document processing, lab report routing, supply chain coordination, and compliance monitoring replacing manual, error-prone processes with governed, auditable, and scalable automated systems.

Cybic embeds compliance controls including HIPAA, GxP, FDA 21 CFR Part 11, and audit trail requirements directly into automation architecture. Every automated action is logged, traceable, and explainable. Role-based access controls and encrypted data protection ensure that automated systems meet the auditability and data integrity standards regulators require across pharmaceutical, biotech, and medical device organizations.

Yes. Cybic designs automation systems to integrate directly with Laboratory Information Management Systems (LIMS), Electronic Health Record (EHR) platforms, ERP systems, and clinical data repositories via custom API development and middleware integration ensuring automation augments your existing infrastructure without requiring a complete system replacement or disrupting live operations.

RPA automates structured, rule-based tasks by mimicking user actions like copying data between systems. Intelligent automation goes further, combining RPA with AI, NLP, and machine learning to handle unstructured data, make context-aware decisions, and adapt to exceptions. In life sciences, this enables automation of complex processes like clinical document review, adverse event reporting, and regulatory submission preparation.

Implementation timelines depend on the complexity and scope of automation. Targeted RPA deployments for well-defined processes can go live in 6-10 weeks. More comprehensive intelligent automation programs involving AI models, multi-system integration, and governance frameworks typically require 3-6 months. Cybic's discovery and scoping phase provides a precise delivery roadmap before any development begins.

No. Cybic maintains a strict policy of no model training on proprietary enterprise data. Your clinical data, research assets, and regulatory documents remain within your governed environment. All AI and automation systems are deployed under strict data governance controls ensuring your intellectual property and patient data are never used to train or improve external models.

High-impact use cases include regulatory document processing and submission preparation, clinical trial data management, pharmacovigilance and adverse event reporting, lab data ingestion and quality control, invoice and procurement automation, and HR onboarding for clinical staff. Cybic conducts a workflow assessment to identify and prioritize the specific processes where automation delivers the fastest and most measurable return in your organization.

Cybic embeds AI governance frameworks with ongoing monitoring, KPI tracking, and auditability built into every deployment. Lifecycle management processes ensure models are retrained responsibly, outputs are continuously reviewed for accuracy and bias, and access controls are regularly audited. This ensures your intelligent automation systems remain explainable, compliant, and aligned with evolving life sciences regulatory standards over their operational lifetime.